Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies
Description
CONCLUSIONS: Our results documented satisfactory in vitro cellular immune response in PAD patients after booster SARS-CoV-2 vaccination. Therefore, even patients with agammaglobulinemia should benefit from vaccination due to the apparent induction of
